Market Currents
Mylan (MYL +1.4%) has pulled out of discussions to buy a stake in Italian pharmaceutical firm...
-
Thursday, March 15, 2012, 2:58 PM ETMylan (MYL +1.4%) has pulled out of discussions to buy a stake in Italian pharmaceutical firm Rottapharm after the selling family wouldn't agree to give up control, nor compromise enough on price. Rottapharm has also held talks with Watson Pharmaceuticals (WPI -0.2%) and Forest Labs (FRX +0.1%), however Watson doesn't appear likely to be a buyer.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
